Table 1 Synthesis of 2-benzazepine derivatives (5–15)a
Laboratories, Inc.), US Pat. 3,894,072; Chem. Abstr., 1975, 83,
114031e; (d) J. A. Meschino (McNeil Laboratories, Inc.), US Pat.
3,828,096; Chem. Abstr., 1974, 81, 136001f; (e) J. A. Meschino
(McNeil Laboratories, Inc.), US Pat. 3,483,186; Chem. Abstr., 1970, 72,
121383x; (f) H. Fujimura and M. Hori (Takeda Chemical Industries,
Ltd.), US Pat. 3,409,607; Chem. Abstr., 1969, 70, 77827c.
3 (a) A. Kamimura, Y. Taguchi, Y. Omata and M. Hagihara, J. Org.
Chem., 2003, 68, 4996; (b) M. Nyerges, A. Viranyi, A. Pinter and L.
Toke, Tetrahedron Lett., 2003, 44, 793; (c) J. C. Martins, K. V.
Rompaey, G. Wittman, C. Tomboly, G. Toth, N. De Kimpe and D.
Tourwe, J. Org. Chem., 2001, 66, 2884; (d) R. Gamez-Montano, M. I.
Chavez, G. Roussi and R. Cruz-Almanza, Tetrahedron Lett., 2001, 42,
9; (e) L. Ollero, L. Castedo and D. Dominguez, Tetrahedron Lett., 1998,
39, 1413; (f) A. G. Griesbeck and H. Mauder, Angew. Chem., Int. Ed.
Engl., 1992, 31, 73; (g) R. A. Holton, M. P. Sibi and W. S. Murphy, J.
Am. Chem. Soc., 1988, 110, 314.
Alcohol
(1e–m)
Product
R1 (alkyl) R (alkyl) (5–15) Yield (%)
1e
1e
1f
1g
1h
1i
1i
1j
1k
1l
1m
3-(MeO)Ph
3-(MeO)Ph
3-(MeO)Ph
3-(PrO)Ph
Et
Et
Me
Et
Me
Et
Me
Et
Et
Et
Et
Me
Et
Me
Et
Et
Et
5
6
7
8
9
10
11
12
13
14
15
55
67
44
58
65
70
74
72
33
48
46
3-(PrO)Ph
3,5-(MeO)2Ph
3,5-(MeO)2Ph
3,5-(MeO)2Ph
3,4,5-(OMe)3Ph Me
3,4-(OCH2O)Ph Et
3,4-(OCH2O)Ph Me
Et
Me
4 (a) D. Basavaiah and A. J. Rao, Chem. Commun., 2003, 604; (b) D.
Basavaiah and T. Satyanarayana, Tetrahedron Lett., 2002, 43, 4301; (c)
D. Basavaiah and T. Satyanarayana, Org. Lett., 2001, 3, 3619; (d) D.
Basavaiah, M. Bakthadoss and S. Pandiaraju, Chem. Commun., 1998,
1639.
a All the reactions were carried out on 2 mmol scale of Baylis–Hillman
alcohols (1e–m) with methanesulfonic acid in alkanenitriles (5 mL) at 150
°C for 6 h. Yields are of the pure compounds obtained after column
chromatography. All the compounds were fully characterized.
5 (a) R. Bishop, in Comprehensive Organic Synthesis, ed. B. M. Trost and
I. Fleming, Pergamon, Oxford, 1991, vol. 6, p. 261; (b) L. I. Krimen and
D. J. Cota, Org. React., 1969, 17, 213; (c) K. V. Emelen, T. D. Wit, G.
J. Hoornaert and F. Compernolle, Org. Lett., 2000, 2, 3083.
6 (a) K. Hoesch, Ber. Dtsch. Chem. Ges., 1915, 48, 1122; (b) J. Houben,
Ber. Dtsch. Chem. Ges., 1926, 59, 2878; (c) P. E. Spoerri and A. S.
DuBois, Org. React., 1949, 5, 387; (d) W. Ruske, in Freidel–Crafts and
Related Reactions, ed. G. A. Olah, Wiley-Interscience, New York,
1964, vol. III, part I, ch. 32; (e) M. Yato, T. Ohwada and K. Shudo, J.
Am. Chem. Soc., 1991, 113, 691; (f) Y. Sato, M. Yato, T. Ohwada, S.
Saito and K. Shudo, J. Am. Chem. Soc., 1995, 117, 3037; (g) R. Kawe-
eki, A. P. Mazurek, L. Kozerski and J. K. Maurin, Synthesis, 1999,
751.
7 (a) D. Basavaiah, A. J. Rao and T. Satyanarayana, Chem. Rev., 2003,
103, 811; (b) E. Ciganek, in Organic Reactions, ed. L. A. Paquette, John
Wiley & Sons, New York, 1997, vol 51, p. 201; (c) D. Basavaiah, P.
Dharma Rao and R. Suguna Hyma, Tetrahedron, 1996, 52, 8001; (d) S.
E. Drewes and G. H. P. Roos, Tetrahedron, 1988, 44, 4653.
8 (a) V. K. Aggarwal, I. Emme and S. Y. Fulford, J. Org. Chem., 2003, 68,
692; (b) K.-S. Yang, W.-D. Lee, J.-F. Pan and K. Chen, J. Org. Chem.,
2003, 68, 915; (c) W. P. Almeida and F. Coelho, Tetrahedron Lett.,
2003, 44, 937; (d) H. Kraiem, M. I. Abdullah and H. Amri, Tetrahedron
Lett., 2003, 44, 553; (e) M. Shi and Y-M. Xu, Angew. Chem., Int. Ed.,
2002, 41, 4507; (f) C. Yu and L. Hu, J. Org. Chem., 2002, 67, 219; (g)
L.-C. Wang, A. L. Luis, K. Agapiou, H.-Y. Jang and M. J. Krische, J.
Am. Chem. Soc., 2002, 124, 2402; (h) S. A. Frank, D. J. Mergott and W.
R. Roush, J. Am. Chem. Soc., 2002, 124, 2404; (i) R. Räcker, K. Döring
and O. Reiser, J. Org. Chem., 2000, 65, 6932; (j) G. Li, J. Gao, X. Wei
II and M. Enright, Org. Lett., 2000, 2, 617; (k) A. G. M. Barrett, A. S.
Cook and A. Kamimura, Chem. Commun., 1998, 2533.
9 (a) D. Basavaiah and P. K. S. Sarma, Chem. Commun., 1992, 955; (b)
D. Basavaiah, M. Krishnamacharyulu, R. Suguna Hyma and S.
Pandiaraju, Tetrahedron Lett., 1997, 38, 2141; (c) H. J. Lee, M. R.
Seong and J. N. Kim, Tetrahedron Lett., 1998, 39, 6223.
10 See ESI† for E/Z of the amides.
11 A plausible mechanism for the formation of allyl amides and
2-benzazepines is presented in the ESI†.
12 A temperature of 150 °C is necessary as at 110 °C 2-benzazepine (5) is
not formed. Also in the case of 1a, even at 150 °C there is no formation
of the corresponding 2-benzazepine derivative.
13 Crystal data for 13: C17H21NO5; M, 319.35; crystal colour, habit: light
yellow, rectangular; crystal dimensions, 0.5 3 0.48 3 0.24 mm; crystal
Fig. 1 ORTEP diagrams of (a) 13 and (b) 15.
treated with methanesulfonic acid (3 mL) at 150 °C for 6 h.12 We
then extended this strategy to representative Baylis–Hillman
adducts (1e–m) to provide the desired 2-benzazepine derivatives
(6–15) in moderate to good yields via reaction with aceto- and
propionitriles (Scheme 3, Table 1). The structures of 13 and 15
were also established by single crystal X-ray crystallography (Fig.
1).13
In conclusion, we have developed a novel strategy involving
tandem construction of C–N and C–C bonds leading to a
convenient one-pot procedure for the synthesis of 2-benzazepine
derivatives from the Baylis–Hillman adducts. We have also
described the stereoselective transformation of the Baylis–Hillman
adducts into (E) or (Z)-allyl amides, thus demonstrating the efficacy
of the Baylis–Hillman adducts as an important source for
exploration of new reactions and stereoselective transformation
methodologies.
We thank DST (New Delhi) for funding this project. We thank
UGC (New Delhi) for recognizing our University of Hyderabad as
a “University with Potential for Excellence (UPE)” and generous
funding and also for a Special Assistance Program in Organic
Chemistry in the School of Chemistry. TS thanks UGC (New
Delhi) for his research fellowship. We also thank the National
Single Crystal X-ray Facility in our School of Chemistry funded by
DST (New Delhi). We thank Professor T. P. Radhakrishnan for
helpful discussions regarding X-ray crystal structures.
system, monoclinic; lattice type, primitive; a
= 10.669(6), b =
Notes and references
13.041(8), c = 12.062(9) Å; b = 93.18(5)°; V = 1675.6(18) Å3; space
1 (a) J. A. May, R. K. Zeidan and B. M. Stoltz, Tetrahedron Lett., 2003,
44, 1203; (b) C. Guillou, J-L. Beunard, E. Gras and C. Thal, Angew.
Chem., Int. Ed., 2001, 40, 4745; (c) C-K. Sha, A-W. Hong and C-M.
Huang, Org. Lett., 2001, 3, 2177; (d) J. Jin and S. M. Weinreb, J. Am.
Chem. Soc., 1997, 119, 2050; (e) J. M. Boente, L. Castedo, R. Cuadros,
J. M. Saa, R. Suau, A. Perales, M. Martinez-Ripoll and J. Fayos,
Tetrahedron Lett., 1983, 24, 2029.
2 (a) R. E. Johnson and C. A. Busacca (Sterling drug, Inc.), US Pat.
5,098,901; Chem. Abstr., 1992, 117, 7949j; (b) P. Croisier and L.
Rodriguez (UCB S. A.), Ger. Offen. 2,733,868 and 2,733,869; Chem.
Abstr., 1978, 88, 152455g and 152456h; (c) J. A. Meschino (McNeil
group, P21/a : b3 (No. 14); Z = 4; m = 0.093 mm21; Dcalcd = 1.266 g
cm23; F000 = 680; l(Mo Ka) = 0.71073 Å; R = 0.0569, wR2
=
0.1845. Crystal data for 15: C15H15NO4; M, 273.28; crystal colour,
habit: light yellow, rectangular; crystal dimensions, 0.47 3 0.42 3 0.40
mm; crystal system, monoclinic; lattice type, primitive; a = 8.096(5),
b = 16.436(8), c = 10.159(8) Å; b = 98.73(5)°; V = 1336.1(15) Å3;
space group, P21/a : b3 (No. 14); Z = 4; m = 0.099 mm21; Dcalcd
=
1.359 g cm23; F000 = 576; l(Mo Ka) = 0.71073 Å; R = 0.0441, wR2
=
suppdata/cc/b3/b310550d/ for crystallographic data in CIF or other
electronic format.
C h e m . C o m m u n . , 2 0 0 4 , 3 2 – 3 3
33